Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Investor type Accelerator
Founders Arvind Gupta Bill Liao Sean O'Sullivan


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 483
Average round size
The average size of a deal this fund participated in
Portfolio companies 229
Rounds per year 53.67
Lead investments 6
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees Soon
Stages of investment

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Food and Beverage
  • Life Science

IndieBio appeared to be the VC, which was created in 2014. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the IndieBio, startups are often financed by SOSV, Velocity, Enterprise Ireland. The meaningful sponsors for the fund in investment in the same round are True Ventures, Supernode Ventures, Starlight Ventures. In the next rounds fund is usually obtained by SOSV, True Ventures, New Crop Capital.

The current fund was established by Arvind Gupta, Bill Liao.

Deals in the range of 1 - 5 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. The fund is generally included in 25-48 deals every year. Comparing to the other companies, this IndieBio performs on 28 percentage points less the average number of lead investments. The typical startup value when the investment from IndieBio is 1-5 millions dollars. The important activity for fund was in 2019. Considering the real fund results, this VC is 19 percentage points less often commits exit comparing to other organizations.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Girihlet, Sun Genomics, BeeFlow. Among the most successful fund investment fields, there are Food and Beverage, Biotechnology. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Machine Learning
Medical Device
09 Dec 2022 San Francisco, California, United States

Prolific Machines

Health Care
Life Science
07 Dec 2022 San Francisco, California, United States

Aja Labs

Plastics and Rubber Manufacturing
$2M30 Nov 2022 San Francisco, California, United States

BioFluff Inc.

$500K25 Nov 2022 Oakland, California, United States


Advanced Materials
Industrial Engineering
23 Nov 2022 Ithaca, New York, United States

BioROSA Technologies

Health Care
Life Science
18 Nov 2022 Massachusetts, United States


Life Science
17 Nov 2022 Geneve, Geneva, Switzerland

Harmony Baby Nutrition

Food and Beverage
Health Care
01 Nov 2022 Boston, Massachusetts, United States


$12M26 Oct 2022 San Francisco, California, United States
Beeflow raises $8.3 million to save the bees AND put them to work

– Beeflow, a startup that announced the close of a $8.3m Series A round, is looking to both save the bees and help farmers be more efficient and effective at the same time.
– The financing round was led by Ospraie Ag Science, with participation from Future VenturesSteve Jurvetson, Jeff Wilke, Vectr Ventures, SOSV’s IndieBio and Grid Exponential.
– The startup uses proprietary scientific technology that essentially makes bees healthier, particularly in cold weather.
– A wealth of research led the company to understand that certain plant-based foods and molecules, when fed to the bees, can reduce the mortality rate of bees by up to 70 percent, and help them perform better in colder weather.
– You might be wondering what I mean by performance. That’s fair.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent IndieBio?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: